Position in NVS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$374,560
+$7,197 QoQ
Shares Held
2,390
-0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,016
of 1,603 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KORNITZER CAPITAL MANAGEMENT INC /KS holds $441,607,402 across 13 Drug Manufacturers - General names. NVS ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
109,014 | $130,754,672 | |
| 2 | JNJ |
Johnson & Johnson
|
325,018 | $82,544,821 | |
| 3 | MRK |
Merck & Co., Inc.
|
539,543 | $69,331,275 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
320,500 | $40,491,970 | |
| 5 | PFE |
Pfizer Inc
|
1,417,822 | $34,141,153 | |
| 6 | AZN |
Astrazeneca PLC
|
148,906 | $28,235,555 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
307,825 | $17,736,876 | |
| 8 | GSK |
GSK plc
|
321,622 | $16,859,425 |
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $374,560 | 2,390 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $367,363 | 2,405 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $295,041 | 2,140 | Shares | Sole | 2026-02-02 | |
| No filing history on record for this holder in this stock. | ||||||